If an employee fails a drug test through DISA's program, it will remain on their account indefinitely. Depending on the industry and/or workplace policy, employees have the opportunity to complete a Return-to-Duty test and process. However, once a Return-to-Duty program is completed, the failed drug test will still remain on the individual's account indefinitely due to owners with zero tolerance.
DISA offers several programs accommodating industry-specific workplace safety needs, including background screening, drug and alcohol testing, DOT-mandated services, occupational health, transportation compliance, entertainment compliance, and more.
DISA's industry-leading vendor partners, combined with an extensive range of drug testing methodologies set our standards higher for customers. Our drug testing solutions offer expanded service offerings, cutting-edge technology, and a single-source solution for all your drug testing needs. By implementing a drug testing program with DISA, you'll find:
On a hair test and oral fluid panel/test certificates, does CBD fall under cannabinoids? YES – Currently, CBD is not listed as an independent substance on any testing panel. DISA drug test (urine, hair, saliva) will screen for THC or cannabinoids.
"Currently, 49 states and the District of Columbia already allow 18 to 20-year-old CDL holders to operate CMVs in intrastate commerce—meaning under-21 drivers may currently drive within state borders, such as from Houston to El Paso or from Miami to Tallahassee." Additionally, the FMCSA proposed a new under-21 commercial driver pilot program for interstate commerce in 2020 that is still pending "thoughts and opinions", which can be found on their website: https://www.fmcsa.dot.gov/newsroom/fmcsa-proposes-new-under-21-commercial-driver-pilot-program. A similar program was launched for military members in 2018 and was proposed two years earlier before officially launching.
There is no test for CBD, DISA’s tests will screen for THC or cannabinoids. Any test that screens for THC or cannabinoids is going to report findings for THC or cannabinoids that exceed the panel thresholds (levels). The origin of the substance will not be considered by the Medical Review Officer (MRO). DISA’s non-DOT corporate policy offers clients the option to customize testing panels.